Proven blue light protection

Studies have shown that lutein and zeaxanthin reduce eye fatigue associated with prolonged exposure to blue light.1

Our blue light patent2 highlights the benefits of FloraGLO® and protecting people of all ages from blue light associated with:

computers, smart phones, sunlight

why floraglo® lutein?

By continuing to conduct research and drive innovation, FloraGLO® lutein has become ‘the blue light brand’ scientifically proven to protect eyes by filtering them from harmful blue light.

Have a question?

25 glorious years

25 glorious reasons

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.


  1. Yagi, A. et al. The effect of lutein supplementation on visual fatigue: A psychophysiological analysis. Appl. Ergon. 40, 1047–1054 (2009).
  2. Kawabata, F. & Tsuji, T. Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans.
  3. Biomed. Res. Tokyo Jpn. 32, 387–393 (2011).
  4. US Patent 9,226,940 B2, Method of Treating Ocular Disorders, Issued Jan. 5, 2016 to Kemin Industries